The glabellar reflex was first described in 1896 by Overend. Since then many names have been applied to this phenomenon, which is characterized by blinking of the eyes in response to various stimuli applied to the face and cranium. Wartenberg (1945) in a review of the subject described the reflex as myotatic in nature and professed that the best way to elicit it consisted of grasping the outer canthus of the eye with thumb and forefinger and then applying a slight blow to the examiner's fingers with a reflex hammer. The stimulus from which the reflex gains its name, however, is a light tap to the glabella.
In normal persons, when the tap frequency is held constant, the blinking stops after the first few taps. In certain patients the reflex blinks continue in response to each glabellar tap for an indefinite period. This is considered clinically to represent the abnormally exaggerated glabellar response.
Delineation of this reflex remained clinical until Kugelberg (1952) conducted an EMG study which characterized the response as a dual one. In his patients a tap to the glabella produced a double response as measured by a recording electrode in the orbicularis oculi muscle. The characteristics of the first response correspond with those of a monosynaptic, myotatic reflex, while the features of the second component are those of a multisynaptic, nociceptive type reflex. The afferent limb of both components involves the trigeminal nerve, since trigeminal rhizotomy abolishes both components; the central connections are as yet unknown.
According to Wartenberg (1945) the clinical usefulness of the glabellar reflex consists of diminution of response on the side of a peripheral facial palsy with preservation of bilateral response or exaggeration in the case of central facial palsy. The almost constant presence of an exaggerated response in cases of postencephalitic Parkinsonism led Wartenberg (1945) to state that the glabellar reflex is pathognomonic of this disease. This concept remained unchallenged until the series of Pearce, Aziz, and Gallagher (1968) in which the occurrence of exaggerated glabellar response was described in relation to various intracranial diseases apart from Parkinsonism. Wartenberg's (1945) (1956) concept that the release originates from disturbance of frontal lobe function. Pearce et al. (1968) No conclusions as to the frequency of a positive glabellar sign in Parkinsonism can be drawn from our data. Also, the present series is not intended to demonstrate the overall effectiveness and safety of L-dopa.
All patients were treated with L-dopa beginning with small doses and reaching maximal doses of 3 to 7 g per day. All patients were receiving L-dopa for at least three months before the judgment was made as to whether the glabellar sign persisted. The glabellar response was considered absent only when a sustained blinking reflex could not be elicited on two separate occasions.
The sign was always evoked with light taps to the glabella by the examiner's index finger. The examiner's arm and hand were held above the patient's head outside his field of vision in order to eliminate startle responses from the observations. The response to L-dopa therapy was graded as good, fair, or minimal. Response was considered good if a patient improved at least one stage, fair if there were definite improvement but no change in the overall stage of disease, and minimal if there were evidence of improved function which was not great enough to expand the patient's ability to carry out the activities of daily living. Some response was shown by all patients in this series.
RESULTS
The glabellar reflex reverted to an unsustained blinking in eight of 16 patients during the administration of L-dopa. Table I is a summary of all patients in the series relating reversal of the glabellar sign to other aspects of their illness. Table II , III, and IV compare reversal of the reflex abnormality with stage of disease, duration of illness, and clinical response to L-dopa respectively. The stage of Parkinsonism was graded according to the scheme of Hoehn and Yahr (1967) . It is of note that, among nine patients in stage III, seven or 78 % demonstrated reversal of the glabellar reflex. In the three stage IV patients reversal occurred in only one patient, and in four stage V patients there were no reversals. Similarly, 70 % reversal occurred in patients who had had Parkinson's disease for less than 10 years compared with only 16'7 % reversal in those with duration of disease greater than 10 years.
These findings would seem to indicate that reversibility of the reflex bears some relation to total severity of the disease. Such interpretations must remain strictly tentative, however, owing to the size of our sample. Of greater significance is the fact that, overall, the reflex reverted to normal in 50% of the patients and that reversal correlated highly with clinical response to L-dopa (see Table IV It is generally agreed that the most important pathological change in Parkinsonism is degeneration of the substantia nigra (Greenfield, 1958) . This lesion may be less severe in idiopathic Parkinsonism than in post-encephalitic Parkinsonism but it is characteristic of both states (Greenfield and Bosanquet, 1953) . Chemically, the lesion is characterized by loss of dopamine from the substantia nigra and from the normally dopamine-rich striatum (Ehringer and Horneykiewicz, 1960) . Catecholamine fluorescence has been demonstrated within the neuronal cell bodies of the substantia nigra (Dahlstrom and Fuxe, 1964 ) but no such dopamine containing neurones can be seen in the striatum using conventional light microscopic techniques (Carlsson, Falck, and Hillarp, 1962) . This is despite the fact that the striatum contains the highest concentration of dopamine in the brain (Sano, Gamo, Kakimoto, Taniguchi, Takesada, and Nishinuma, 1959) . Using specialized techniques the striatal dopamine was subsequently shown to exist within a dense meshwork of very fine nerve terminals in the striatum (Dahlstrom and Fuxe, 1965) .
These observations have led to the concept of a nigrostriatal dopamine containing pathway. Anden, Carlsson, Dahlstrom, Fuxe, Hillarp, and Larsson (1964) have shown that experimental lesions in the substantia nigra of rats lead to loss of dopamine from the ipsilateral striatum. These investigators have also demonstrated that, within the first few days after ablation of the striatum, there is increased catechol fluorescence in the neuronal cell bodies of the ipsilateral substantia nigra (Anden, Dahlstrom, Fuxe, Larsson, 1965) . When the animals were killed three to fourweeks afterplacement of the same lesion, these workers observed marked loss of fluorescence along with degenerative changes in these same neurone cell bodies, especially in the pars compacta of the substantia nigra. These findings were felt to support the theory of a nigro-striatal tract made up of dopaminergic neurones with cell bodies in the substantia nigra and fine axon terminals forming a dense meshwork within the ipsilateral striatum. Observations concerning this pathway have been made in primates by Poirier and Sourkes (1965) and Poirier, Sourkes, Bouvier, Bouchet, and Carabin (1966) . These workers reported marked cell loss in the substantia nigra along with reduced dopamine levels in the striatum after interruption of the nigrostriatal pathway by lesions placed in the pars compacta of the ipsilateral substantia nigra.
Dopamine acts as an inhibitory neurotransmitter in most species (Horneykiewicz, 1966) . Of greater significance, however, is the demonstration that dopamine has an inhibitory effect on the neurones of the mammalian caudate nucleus (McLennan and York, 1967) .
The therapy of Parkinsonism with L-dopa presupposes that L-dopa is converted to dopamine, which then acts at the dopamine receptor sites within the brain (Klawans, 1968) . Chronic oral L-dopa therapy results in increased levels of both dopamine and homovanillic acid, the major catabolic product of dopamine, in spinal fluid of Parkinsonian patients (Klawans and Weber, 1969; Weiner, Harrison, and Klawans, 1969) . The simultaneous elevation of both dopamine and homovanillic acid in the CSF of patients receiving L-dopa demonstrates that such therapy does in fact increase dopamine synthesis and concentration within the blood brain barrier. The increased amounts of dopamine can then reinstate the normal dopaminergic influence of the nigral neurones on the striatum. It is our contention that dopaminergic nigrostriatal pathways normally play a role in suppression of at least thenociceptive portion of the glabellar response and perhaps the proprioceptive portion as well. The lack of habituation in the nociceptive component of the response observed by Rushworth (1962) in Parkinsonian patients, together with the pathology of the disease would suggest that in these patients theprimitive glabellarreflex has been released from the inhibitory influence of the striatum. Reversal of the sustained glabellar reflex in 50% of our Parkinsonian patients receiving L-dopa lends support to this hypothesis.
The reversal of the glabellar reflex by L-dopa in these patients is of theoretical importance. It is the first reported instance in which a reflex resulting from structural changes within the brain can be reversed by pharmacological means. This would appear to exemplify not only reinstatement of central inhibition, but, more specifically, inhibition of striatal neurones.
Despite the consistent basal ganglia abnormalities in Parkinson's disease the contribution of cortical pathology to the syndrome has not been ruled out. Adams, Van Bogaert, and Vander Eecken (1964) have noted that neuronal loss in the cortex with reactive gliosis may be more characteristic of Parkinson's disease than has been recognized in the past. In a series of 250 Parkinsonian patients who were subjected to pneumoencephalography as a preliminary to therapeutic stereotactic surgery, Selby (1968) found evidence for cortical atrophy in 57-2 %. In two of our patients in whom there were overt signs of organic dementia the glabellar reflex remained exaggerated despite L-dopa therapy. Thus the sustained glabellar response may also result from diffuse cortical disease as suggested by DennyBrown (1956) and by Pearce et al. (1968) .
CONCLUSIONS
It appears that the sustained glabella response may be a release phenomenon resulting from either loss of the inhibitory effect of dopamine on the striatum, or from diffuse cortical dysfunction. The second mechanism may also involve the basal ganglia as a common final pathway. Oral therapy with L-dopa, which reinstates the inhibitory effect of dopamine to receptor sites in the striatum of Parkinsonian patients often leads to reversal of the glabellar response to that seen in normal adults. This supports the concept that the appearance of the abnormal reflex is related to loss of dopamine inhibition. The fact that L-dopa therapy failed to reverse the sustained glabellar reflex in patients with clinical evidence of organic dementia lends support to the hypothesis that the exaggerated glabellar response may also result from diffuse cortical disease. This cortically originating mechanism would not directly involve the dopamine input to the striatum.
SUMMARY
The effect of L-dopa therapy on the glabellar reflex in Parkinsonian patients is presented. The 
